Homarylamine (INN; also known as 3,4-methylenedioxy-N-methylphenethylamine and MDMPEA) is a substituted phenethylamine. It is the N-methylated analog of MDPEA. Homoarylamine was patented as an antitussive in 1956, but has never been used medically as such.
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||179.21572 g/mol g·mol−1|
|3D model (JSmol)|
- Hydrastine, an alkaloid derivative of homarylamine
- "International Non-Proprietary Names for Pharmaceutical Preparations" (PDF). Chronicle of the World Health Organization. 12 (3). 1958.
- U.S. Patent 2,820,739
(and close relatives)